Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 30 for:    mRNA-1273 | COVID
Previous Study | Return to List | Next Study

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04283461
Recruitment Status : Active, not recruiting
First Posted : February 25, 2020
Last Update Posted : June 11, 2021
Sponsor:
Collaborator:
ModernaTX, Inc.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 22, 2022
Estimated Study Completion Date : November 22, 2022